Hospira announced that it is investing $120 million to expand its McPherson manufacturing plant over the next five years. The company said it will expand capacity, install automated visual inspection systems, and increase production lines as part of its capital improvement and modernization project. The McPherson site produces generic injectable and biologics in a variety of delivery systems.
The expansion is also expected to open an additional 150 jobs in the area. “We’re expecting the majority of those (new jobs) to be on the back end [of the five-year timeline]. There are some in the first years, but most are in the last years. Part of it is we’re doing the investment and adding things at the plant. Once those are completed is when most people will come into play,” said Hospira spokeswoman Tareta Adams. Read the full story
